Allergies in Focus, Tales from the Less Explored World: Prevalence, Allergens, and Treatment Strategies in Latin America and Africa.

In recent years, there has been a significant increase in the prevalence of allergies worldwide, posing a growing public health concern. It is essential to understand the dynamics of allergy prevalence, the most common allergens, and therapeutic strategies in regions such as South America and Africa.

This special issue delves into the specific challenges facing these regions, highlighting the major allergens prevalent in these areas, and exploring innovative therapeutic approaches tailored to their populations. To explore deeper into these aspects, this edition aims to contribute to a better understanding of allergies on a global scale and report specific interventions for effective management.

We welcome all article types accepted by Frontiers. Topics may be related, but not exclusively to:
- Prevalence of allergy among different South American and African populations
- The discovery and/or characterization of distinct allergens in South America/Africa
- The study of the influence of environmental factors on allergy outcomes, predisposition, and prevalence
- Relationship between allergy and the microbiota
- Role of the microbiota in the pathogenesis of allergic diseases.
- Microbiota intervention as a therapeutic target for allergy
- Treatment strategies and immunotherapy studies
- Experimental models for allergy physiological studies and immune intervention options
- Exploring allergies and eosinophilic diseases in South America and Africa populations

Keywords: Allergy, hypersensitivity reactions, eosinophilic disease, allergy experimental models, immunotherapy, microbiota

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.